Robert E. JR Brown

CIK 1579672 · last filed 2022-12-02

Robert E. JR Brown is a corporate insider who has filed 14 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing, for ANIP, was dated Aug 18, 2023. Across all open-market trades the lifetime net is −$30.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $159.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$159.93M

Companies

3

Total Filings

14

Lifetime Open-Market Net

-$30.80M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ANIP Director 2,019,259 $79.20 $159.93M -$30.80M 7 2022-12-02
ANI PHARMACEUTICALS INC (FOLD) Delisted Director 21,394 $14.49 $310.0K $0 5 2019-05-17
ANI PHARMACEUTICALS INC (BPAX) Delisted Director $0 1 2013-07-16

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-08-18 ANIP Notice (144) −15,977 -$951.6K EDGAR
2022-12-02 ANIP Sell (S) −800,000 -$30.80M EDGAR
2022-04-29 ANIP Grant (A) +10,049 $0 EDGAR
2021-03-25 ANIP Grant (A) +9,292 $0 EDGAR
2020-04-14 ANIP Grant (A) +7,119 $0 EDGAR
2019-05-17 ANI PHARMACEUTICALS INC (FOLD) Delisted Exer (M) +2,209 $45.1K EDGAR
2019-04-01 ANI PHARMACEUTICALS INC (FOLD) Delisted Grant (A) +2,584 $0 EDGAR
2018-06-08 ANI PHARMACEUTICALS INC (FOLD) Delisted Grant (A) +1,200 $0 EDGAR
2017-04-04 ANI PHARMACEUTICALS INC (FOLD) Delisted Grant (A) +1,000 $0 EDGAR
2016-11-16 ANI PHARMACEUTICALS INC (FOLD) Delisted Exer (M) +5,458 $96.9K EDGAR
Showing 110 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.